Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination
In respondents with MFS, LDS, or vEDS, we uncovered no evidence of an increase in CVEs in the 30 days following COVID-19 illness, with the possible exception of dysrhythmia. In light of the absence of a substantial increase in self-reported CVEs in the 30 days following COVID-19 vaccination, these data are in keeping with the recommendation from the Marfan Foundation Professional Advisory Board that all eligible persons be vaccinated for COVID-19.
Authors
- Erica Brittain (ORCID: https://orcid.org/0000-0003-3370-6598)
- Gretchen MacCarrick (ORCID: https://orcid.org/0000-0003-4286-0693)
- Allyson Mateja (ORCID: https://orcid.org/0000-0002-2810-478X)
- Harry C. Dietz (ORCID: https://orcid.org/0000-0002-6856-0165)
- Jonathan Fintzi (ORCID: https://orcid.org/0000-0002-6361-702X)
- Pamela A. Frischmeyer‐Guerrerio (ORCID: https://orcid.org/0000-0003-2259-5546)
- Anthony L. Guerrerio (ORCID: https://orcid.org/0000-0003-2458-7160)
Institutions
- National Institutes of Health (US)
- Howard Hughes Medical Institute (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institute of Allergy and Infectious Diseases (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1371/journal.pone.0315499
- Citations
- 1
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Howard Hughes Medical Institute
- U.S. Department of Health and Human Services
- Johns Hopkins University
- National Institutes of Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- NHLBI Division of Intramural Research